Effect of hens fed dietary flaxseed with and without a fatty liver supplement on hepatic,plasma and production characteristics relevant to fatty liver haemorrhagic syndrome in laying hens

1. Two long-term experiments were conducted with Single Comb White Leghorn (SCWL) hens (line UCD-003) predisposed to fatty liver haemorrhagic syndrome (FLHS). The first investigated the effect of adding a fatty liver supplement to the diet of laying hens prior to the onset of lay, and continuing either until peak production or throughout 39 weeks into lay. The second experiment, lasting 9 months into lay, investigated the effect of adding a fatty liver supplement, with or without 100 g/kg dietary ground flaxseed, to the diet. Body weight, feed intake, plasma triglycerides (in experiment 2) and egg production were measured throughout the experiment. Liver weight, liver fat content, liver malondialdehyde (MDA) content and liver haemorrhage score and fatty acid content of liver fat (in experiment 2) were measured at the end of each experiment. 2. In experiment 1, hens given diets containing the fatty liver supplement had higher egg production and eggshell strength, but there was no difference in liver parameters including MDA content or haemorrhage score compared with controls. 3. At the end of experiment 2, hens on 100 g/kg flaxseed diets had lower body weight, liver weight, liver dry matter and fat content, and plasma triglyceride concentrations than hens given the control diets. 4. Liver haemorrhage score was positively correlated with liver weight, but not with liver fat content, plasma triglyceride concentration or liver MDA content. This suggests that reducing the liver lipid content or feeding fatty liver supplements may not be as effective in controlling FLHS as controlling the size of the liver.     

Combinations of alfalfa hay and wet corn gluten feed in limit-fed growing diets for beef cattle

Two experiments were conducted to evaluate the effects of alfalfa hay (AH) and wet corn gluten feed (WCGF) combinations on ADG and gain efficiency of cattle limit-fed growing diets. In Exp. 1, crossbred beef steers (n = 220; initial BW = 262 kg) were limit-fed diets consisting of steam-flaked corn and 40% WCGF (DM basis) with 0, 10, or 20% ground AH (0AH, 10AH, and 20AH, respectively). A fourth diet containing 20% ground AH and steam-flaked corn served as a control. All diets were fed once daily at 1.8% of BW (DM basis). Growing period ADG, gain efficiency, and dietary NE calculated from performance data decreased linearly (P < 0.01) with addition of AH to diets containing WCGF. Rate of DMI increased linearly (P < 0.05) with AH addition to diets containing WCGF. Following the growing period, steers were finished on a common diet offered ad libitum. Gain efficiencies during the finishing period were higher (P < 0.05) for steers fed the 20AH diet than for steers fed the control diet. In Exp. 2, crossbred beef heifers (n = 339; initial BW = 277 kg) were limit-fed diets containing steam-flaked corn with 10, 20, or 30% ground AH and 0, 40, or 68% WCGF in a 3 x 3 factorial arrangement, fed once daily at 1.6% of BW (DM basis). An AH x WCGF interaction occurred (P < 0.05) for growing period ADG and gain efficiency. Increasing AH or WCGF decreased cattle ADG, gain efficiency, and dietary NE with the exception of heifers fed 30AH/40WCGF, which had ADG that did not differ (P > 0.10) from that of heifers fed 20AH/0WCGF or 30AH/0WCGF, and which had greater gain efficiencies (P < 0.05) than heifers fed 30AH/0WCGF. Rate of DMI increased linearly (P < 0.01) with increasing AH and decreased linearly (P < 0.01) with increasing WCGF. Heifers were finished on diets containing 33% WCGF with 0 or 0.5% added urea (DM basis) offered ad libitum. Increasing WCGF in growing diets tended (linear, P < 0.10) to increase finishing ADG and gain efficiency, whereas increasing AH decreased (linear, P < 0.05) kidney, pelvic, and heart fat, and the percentage of carcasses grading USDA Prime. Urea tended to increase ADG (P < 0.10), but decreased (P < 0.04) the percentage of carcasses grading USDA Choice. Results suggest that the value of WCGF relative to steam-flaked corn in limit-fed growing diets might be improved in diets containing 30% AH relative to diets containing 10 or 20% AH.     

Sodium nitroprusside-induced deliberate hypotension to facilitate patent ductus arteriosus ligation in dogs

OBJECTIVE: To report the use of sodium nitroprusside to induce deliberate hypotension to reduce hemorrhage and facilitate surgical ligation of complicated patent ductus arteriosus (PDA) in dogs. STUDY DESIGN: Retrospective study. ANIMALS: Six dogs. METHODS: Hemorrhage occurred during surgical ligation of PDA in 5 dogs. Surgical dissection and isolation of the PDA were very difficult in a sixth dog that was considered to be at increased risk for ductus rupture. Sodium nitroprusside (5 to 25 microg/kg/min intravenously) was administered to these 6 dogs to induce hypotension to reduce blood loss and facilitate surgical ligation of the PDA. RESULTS: Sodium nitroprusside infusion reduced blood pressure (mean arterial pressure, 45 to 60 mm Hg) within 5 to 10 minutes and hemorrhage from the PDA, facilitating its surgical ligation. Recovery from surgery and anesthesia was uneventful in all 6 dogs. CONCLUSIONS: Sodium nitroprusside infusion can be used to induce deliberate hypotension in dogs to facilitate surgical ligation of PDA. CLINICAL RELEVANCE: Sodium nitroprusside infusion produces hypotension within 5 to 10 minutes and is easy to control, rapidly abates, and should help to facilitate surgical ligation of PDA.     

Cloning,expression, purification,and biological activity of five feline type I interferons

Type I interferons (IFN) are important mediators of the host defense against viral infections in mammals. In humans multiple subtypes of IFN-alpha exist, most of which possess antiviral activity. Little is known about the type I IFN genes in cats and the role they may play in feline immunological responses to viruses. We have isolated cDNAs encoding five feline IFN-alpha (feIFN) subtypes that share from 95 to 99% amino acid sequence identity. FeIFN-alpha5 has five additional amino acids inserted at position 139, which are not present in the other four subtypes. Sequence identity of the feIFN proteins encoded by the five clones compared to human IFN-alpha2 is approximately 60%. Unlike most of the human subtypes, each of the five feline IFN sequences has an N-glycosylation recognition site. Expression of all five feIFN-alpha subtypes in Chinese hamster ovary (CHO) cells was confirmed by Western blot analysis, and all resulting proteins were glycosylated. The antiviral activity of each feIFN-alpha subtype produced in transiently transfected CHO cell cultures was tested in vitro. In addition, subtype feIFN-alpha6 was expressed in the yeast, Pichia pastoris. The resulting secreted mature recombinant protein was purified and demonstrated significant antiviral activity and induction of 2',5'-oligoadenylate synthetase activity in vitro.     

Nitric oxide,inducible nitric oxide synthase and inflammation in veterinary medicine

Inflammation is a process consisting of a complex of cytological and chemical reactions which occur in and around affected blood vessels and adjacent tissues in response to an injury caused by a physical, chemical or biological insult. Much work has been performed in the past several years investigating inducible nitric oxide synthase (NOS, EC 1.14.13.39) and nitric oxide in inflammation. This has resulted in a rapid increase in knowledge about iNOS and nitric oxide. Nitric oxide formation from inducible NOS is regulated by numerous inflammatory mediators, often with contradictory effects, depending upon the type and duration of the inflammatory insult. Equine medicine appears to have benefited the most from the increased interest in this small, inflammatory mediator. Most of the information on nitric oxide in traditional veterinary species has been produced using models or naturally occurring inflammatory diseases of this species.